明天的药物
本,一个人患有慢性淋巴细胞白血病股份新治疗方案可能对他意味着什么。
他们不会让步
5 courageous voices on why investment in new medicines matters.\r\n"}}" id="text-28885cb293" class="cmp-text">
新药5勇敢的声音为什么投资很重要。
The scientists who develop new medicines and the patients who live with disease all have one thing in common – tenacity. In their own words, hear how curiosity, creativity, and resilience help them achieve every major breakthrough and overcome each setback. Because good enough is never enough.\n"}}" id="text-7c6ad4eb2f" class="cmp-text">
科学家们开发新的药物和生活与疾病的患者都有一个共同点——坚韧。用他们自己的话说,听到有好奇心,创造力和适应力帮助他们实现每一个重大突破,克服每一个挫折。因为好永远是不够的。
“The way we’re accelerating science is unbelievable. In two or three years, things may look very different than they do today.\r\n
So we follow the science. Science means experiments and some experiments work, some don’t. But what happens is you learn. You learn why it didn’t work. You learn how to make it better.
\r\nWe have to continue to invest in our vision, learn from failures and build on our successes. Because as long as patients are still suffering from disease, nothing’s good enough.”
\r\n– Ahmed Kotb, M.D., Vice President, U.S. Medical Affairs, Oncology, AbbVie
\r\n"}}" id="text-e7df175181" class="cmp-text">“我们加速科学是难以置信的。在两到三年内,事情比他们今天看起来非常不同。
所以我们遵循科学。科学实验和一些实验工作,一些没有。但你学习。你学习为什么它不工作。您将学习如何使它更好。
我们必须继续投资于我们的视野,从失败中学习并建立在我们的成功。因为只要患者还患有疾病,什么都不够好。”
- - - - - -Ahmed Kotb医学博士、副总裁、美国医疗事务,肿瘤学,AbbVie
“The way we’re accelerating science is unbelievable. In two or three years, things may look very different than they do today.\r\n
So we follow the science. Science means experiments and some experiments work, some don’t. But what happens is you learn. You learn why it didn’t work. You learn how to make it better.
\r\nWe have to continue to invest in our vision, learn from failures and build on our successes. Because as long as patients are still suffering from disease, nothing’s good enough.”
\r\n– Ahmed Kotb, M.D., Vice President, U.S. Medical Affairs, Oncology, AbbVie
\r\n"}}" id="text-494ff2b3dd" class="cmp-text">“我们加速科学是难以置信的。在两到三年内,事情比他们今天看起来非常不同。
所以我们遵循科学。科学实验和一些实验工作,一些没有。但你学习。你学习为什么它不工作。您将学习如何使它更好。
我们必须继续投资于我们的视野,从失败中学习并建立在我们的成功。因为只要患者还患有疾病,什么都不够好。”
——艾哈迈德Kotb,医学博士、副总裁、美国医疗事务,肿瘤学,AbbVie
“When I first heard the word ‘cancer,’ I immediately started thinking ‘I’m not going to see my kids grow up.’ It was a really hard thing to grapple with emotionally. But I’m an engineer, my mindset is to be a problem solver. I took my oncologist’s paperwork and I looked up all of the options. I started compiling my own data, creating a database where I could cross-reference genetic markers, treatments and age. My wife and I spent time looking into doctors who specialized in this type of cancer in younger patients.\r\n
If I need treatment again in the future, I think there will be one that is right for me down the road, because I have seen how the field for this cancer has advanced in the time I've had it.”
\r\n– Ben, lives with chronic lymphocytic leukemia
\r\n"}}" id="text-d404450e35" class="cmp-text">“当我第一次听到“癌症”这个词我立即开始思考“我不会看到我的孩子们长大了。“这是非常困难的应对情绪。但我是一个工程师,我的心态是问题解决者。我把我的肿瘤学家的文书工作,我抬头一看所有的选项。我开始整理自己的数据,创建一个数据库,我可以交叉引用遗传标记,治疗和年龄。我和我妻子花时间调查医生专门从事这种类型的癌症在年轻病人。
如果我将来需要治疗,我认为将会有一个适合我,因为我已经看到这个癌症的领域拥有先进的时间我 了它。”
- - - - - -本,生活在慢性淋巴细胞白血病
坚韧的锚是解决任何真正的挑战。
奥布里·亚当斯博士区域领先,TNT和偏头痛,美国医疗事务AbbVie解释如何在科学前进的道路。
“I have spent a lot of time as an epidemiologist trying to understand the burden of disease. So much of science is quantifying the world around us and finding answers to unanswered questions. The investment in the future is critical because, in the work we do, things don’t happen overnight. You have to think today about what the questions are tomorrow.\n
Innovation requires a vision and the way to innovate is to take small steps each day. It’s that willingness to learn and ask the next question. Tenacity is the anchor of solving any real challenge. It’s what keeps you there, keeps you trying, keeps you driven to find that answer.”
\n– Aubrey Adams, Ph.D., Area Lead TNT & Migraine, U.S. Medical Affairs, AbbVie
\n"}}" id="text-a8116811fb" class="cmp-text">“我花了很多时间作为流行病学家试图了解疾病的负担。如此多的科学量化我们周围的世界,发现悬而未决的问题的答案。投资在未来是至关重要的,因为在我们所做的工作,事情不会在一夜之间发生。你必须明天今天思考的问题是什么。
创新需要远见和创新的方法是采取小步骤每一天。那就是愿意学习和问下一个问题。坚韧的锚是解决任何真正的挑战。是什么让你那里,让你尝试,让你找到这个答案。”
- - - - - -奥布里·亚当斯博士地区铅TNT和偏头痛,美国医疗事务,AbbVie
“For so long, it hurt to move. Nobody knew what was wrong with me, that I had an autoimmune skin disease. I went seven years from when the symptoms started to when I actually found out what it was: hidradenitis suppurativa. What kept me going and kept me positive through the years was hope for a better, more comfortable life where I wouldn’t have to deal with pain and discomfort.\r\n
Challenges or failures happen, and it is not a reason to stop.”
\r\n– Will, lives with hidradenitis suppurativa
\r\n"}}" id="text-326e5a90c2" class="cmp-text">“这么长时间,它伤害。没有人知道我究竟是怎么了,我有一种自身免疫性皮肤病。我去七年从症状开始时当我发现这是什么:位患化脓性汗腺炎。使我什么,让我积极多年来是希望更好,更舒适的生活,我不需要处理疼痛和不适。
挑战或故障发生,它不是一个理由停止。”
- - - - - -将生活与位患化脓性汗腺炎吗
回答棘手的问题始于研发投资
马德拉舞Kapoor医学博士,全球医疗事务,神经科学AbbVie解释了为什么投资早期科学和发现是至关重要的。
“Each disease impacts different patients in different ways, so the same treatment won’t work for everyone. And when science and our understanding of disease changes, so does our thinking on how we want to impact patients. The target is constantly evolving.\r\n
We’re all working collectively to find that next frontier, to pioneer that next transformational medicine. Discovery scientists, chemists, pharmacists, statisticians and data scientists. It takes a village.
\r\nToday’s needs are different from yesterday’s and tomorrow’s needs will be different still. We must keep pushing forward to help more patients live the way they want to live. There’s no better reward than to be part of that revolution.”
\r\n- Mudra Kapoor, M.D.,Global Medical Affairs, Neuroscience, AbbVie
\r\n"}}" id="text-c08149b98f" class="cmp-text">“每个疾病以不同的方式影响不同的病人,所以同样的待遇不会对每个人都有效。当科学和我们对疾病的理解的变化,那么我们思考我们想要如何影响病人。目标是不断发展的。
我们都是集体合作,发现下一个前沿,下转换医学的先驱。发现科学家,化学家,药剂师、统计学家和数据科学家。它需要一个村庄。
今天的需要不同于昨天的和明天的需求将有所不同。我们必须继续推动帮助更多的病人他们想要的生活方式生活。没有比这更好的奖励比革命的一部分。”
- - - - - -马德拉舞Kapoor医学博士全球医疗事务,神经科学,AbbVie
\r\n
Media Inquiries:
\r\nName: Jane Woo
\r\nEmail: jane.woo@abbvie.com
\r\nCall: +1 224-864-3846
媒体询问:
名称:简吸引
电子邮件:(电子邮件保护)
电话:+ 1 224-864-3846
外部链接
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.\r\n
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
\r\n"}}" id="text-bf3fb6e3b6" class="cmp-text">除非另有规定,所有产品名称出现在本网站商标或许可AbbVie Inc .旗下的子公司或分支机构。没有使用任何AbbVie商标,商号,或贸易服装在这个网站可能没有AbbVie Inc .的事先书面授权,除了确定公司的产品或服务。
版权©2023 AbbVie Inc .北芝加哥,伊利诺斯州,美国
